Pierre Massion to direct Vanderbilt-Ingram’s early detection initiative

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

PIERRE MASSION will direct the Vanderbilt-Ingram Cancer Center’s Cancer Early Detection and Prevention Initiative. Massion is the Cornelius Vanderbilt Professor of Medicine, an Ingram Professor of Cancer Research and co-leader of the VICC Cancer Health Outcomes and Control Research Program.

“The prevention of cancer and the development of more effective strategies to detect cancer precursors and early-stage cancers, when treatment may be most effective, remain top goals of Vanderbilt University Medical Center and we are pleased that Pierre has agreed to lead this new initiative,” said Jennifer Pietenpol, executive vice president for research at VUMC and director of the cancer center. “As we develop a better understanding of environment and lifestyle factors, and common genetic variants that are associated with higher or lower risk of certain cancers, we may be able to use that knowledge to identify individuals who may benefit from early detection and prevention strategies.”

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login